Built to Scale: From Breakthrough Science to Commercial Success
Join us for an exclusive live webinar with Tim Cloutier, PhD, a seasoned commercial executive with over 25 years of experience driving growth and innovation across life sciences, biotech, diagnostics, and AI-enabled technology markets.
Tim has led commercialization, product development, and fundraising efforts at leading companies, including Codex DNA, Flywheel, BioLegend, Shadowbox, and CRISPR QC, scaling businesses from $1M to $400M+ in revenue. His fundraising achievements include IPO preparation and execution ($120M), Series D ($55M), and multiple Series A rounds.
In this session, Tim will share his insights on turning breakthrough science into scalable, market-dominant ventures, with lessons for founders, startup teams, and university spinouts. He will discuss strategies for:
Commercializing scientific innovation
Building high-performing teams and infrastructures
Navigating fundraising and investor relations
Scaling startups from early-stage to commercial success
The webinar concludes with a live Q&A, giving attendees the chance to ask Tim questions about growing startups, fundraising, and market strategy.
About the Speaker:
Tim Cloutier, PhD, is Chief Commercial Officer at CRISPR QC, Board Member and Commercial Advisor at Intactis Bio, and Board Advisor at ryniX.ai. He also serves as an Entrepreneur-in-Residence at UC San Diego and mentors early-stage ventures through Janus Innovation Hub. Tim’s rare combination of scientific acumen, operational discipline, and strategic foresight has helped both emerging and mature companies accelerate commercial success.
Who Should Attend:
Startup founders & entrepreneurs
University researchers and spinouts
Investors and business development professionals
Anyone interested in biotech, AI, and high-tech commercialization
Reserve Your Spot Now